Transcriptional control of granulocyte and monocyte development
The DOI matches its Crossref record; 199 of the 200 references it cites were found in a registry or an index.
Abstract
PU.1 directs the hematopoietic stem cell to the lymphoid-myeloid progenitor (LMP) and interacts with GATA-binding protein 1 to inhibit commitment to the megakaryocyte-erythroid progenitor. The CCAAT/enhancer-binding protein (C/EBP)alpha then directs the LMP to the granulocyte-monocyte progenitor (GMP) stage, while inhibiting lymphoid development via cross-inhibition of Pax5 and potentially other regulators. Increased PU.1 activity favors monocytic commitment of the GMP. Induction of PU.1 by C/EBPalpha and interaction of PU.1 with c-Jun elevates PU.1 activity. Zippering of C/EBPalpha with c-Jun or c-Fos also contributes to monocyte lineage specification. An additional factor, potentially an Id1-regulated basic helix-loop-helix protein, may be required for the GMP to commit to the granulocyte lineage. Egr-1, Egr-2, Vitamin D Receptor, MafB/c: Fos and PU.1:interferon regulatory factor 8 complexes direct further monocytic maturation, while retinoic acid receptor (RAR) and C/EBPepsilon direct granulopoiesis. Both C/EBPalpha and RARs induce C/EBPepsilon, and PU.1 is also required, albeit at lower levels, for granulocytic maturation. HoxA10 and CAAT displacement protein act as transcriptional repressors to delay expression of terminal differentiation. Gfi-1 and Egr-1,2/Nab2 complexes repress each other to maintain myeloid lineage fidelity. NF-kappaB directly binds and cooperates with C/EBPbeta to induce the inflammatory response in mature myeloid cells and potentially also cooperates with C/EBPalpha to regulate early myelopoiesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“its action is also important or indispensable for sustained generation of all known hematopoietic precursors that have lymphoid developmental potentials (1–9).”
From Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development (2019) · cites this paper as [4]
In the citing paper
“In myeloid, dendritic, and B lineage cells, PU.1 is a major contributor to the positive regulation of genes that establish lineage-specific identity (4, 17, 19).”
From Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development (2019) · cites this paper as [4]
In the citing paper
“the CEBP/α/PU.1 pathway is involved in the regulation of monopoiesis and granulopoiesis (143, 144) and serves as a candidate for regulating proliferation in microglia.”
From Microglia in Alzheimer's disease (2017) · cites this paper as [143]
In the citing paper
“The transcription factor PU.1 serves as a master regulator of myeloid cells70. PU.1 plays a crucial role in determining macrophage lineages and microglial genesis and is a major factor in selecting the set of enhancers expressed by microglia.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [70]
Citations
Cites
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617 · cited 2×
“Pluripotent hematopoietic stem cells (HSC) give rise to a lin IL7Ra KitþSca-1 CD34þFcgRlo common myeloid progenitor (CMP), which in turn gives rise to a lin IL7Ra KitþSca-1 CD34þFcgRhi granulocyte-monocyte progenitor (GMP; Akashi et al., 2000; Traver et al., 2001).”
BackgroundAP-1 in cell proliferation and survival
Shaulian, E., & Karin, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204383 · Cited by 1,736
Umesono, K., Murakami, K. K., Thompson, C. C., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90020-y · Cited by 1,716
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
The JNK signal transduction pathway
Weston, C. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00258-1 · Cited by 1,528
Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential
Adolfsson, J., Månsson, R., Buza-Vidas, N., Hultquist, A., Liuba, K., Jensen, C. T., Bryder, D., Yang, L., Borge, O.-J., Thoren, L. A. M., et al. (2005) · Cell · doi:10.1016/j.cell.2005.02.013 · Cited by 1,236
Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
Sha, W. C., Liou, H.-C., Tuomanen, E. I., & Baltimore, D. (1995) · Cell · doi:10.1016/0092-8674(95)90415-8 · Cited by 1,157
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · cited 2×
“PU.1( / ) mice lack B cells and monocytes and have greatly reduced neutrophils (Scott et al., 1994; McKercher et al., 1996).”
BackgroundDescombes, P., & Schibler, U. (1991) · Cell · doi:10.1016/0092-8674(91)90531-3 · Cited by 990
Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10193 · Cited by 959 · cited 1×
“Co-immunoprecipitation demonstrates interaction of bacterially expressed C/EBPa or C/EBPb with bacterially expressed or in vitro translated p50 or p65, mapping to the bZIP domain of C/EBP and to the Rel homology domain of p65 (Matsusaka et al., 1993; Stein et al., 1993).”
BackgroundThe macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954
Stepwise Reprogramming of B Cells into Macrophages
Xie, H., Ye, M., Feng, R., & Graf, T. (2004) · Cell · doi:10.1016/s0092-8674(04)00419-2 · Cited by 947
Zhang, D.-E., Zhang, P., Wang, N.-D., Hetherington, C. J., Darlington, G. J., & Tenen, D. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.569 · Cited by 910 · cited 1×
“…and eosinophils; although they retain monocytes in their peripheral blood, Mac-1þ /Gr-1 monocytes are reduced in their fetal and newborn livers, and marrow CFU-M numbers are reduced twofold despite expression of the macrophage colony stimulating factor receptor (MCSFR; Zhang et al., 1997).”
BackgroundFazi, F., Rosa, A., Fatica, A., Gelmetti, V., De Marchis, M. L., Nervi, C., & Bozzoni, I. (2005) · Cell · doi:10.1016/j.cell.2005.09.023 · Cited by 894
Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
Guzman, M. L., Neering, S. J., Upchurch, D., Grimes, B., Howard, D. S., Rizzieri, D. A., Luger, S. M., & Jordan, C. T. (2001) · Blood · doi:10.1182/blood.v98.8.2301 · Cited by 758
Regulation of B lymphocyte and macrophage development by graded expression of PU.1
DeKoter, R. P., & Singh, H. (2000) · Science · doi:10.1126/science.288.5470.1439 · Cited by 749 · cited 2×
“1( / ) progenitors induces B cells at lower levels and monocytes at higher levels (DeKoter and Singh, 2000); exogenous PU.”
BackgroundLangerhans cells arise from monocytes in vivo
Ginhoux, F., Tacke, F., Angeli, V., Bogunovic, M., Loubeau, M., Dai, X.-M., Stanley, E. R., Randolph, G. J., & Merad, M. (2006) · Nature Immunology · doi:10.1038/ni1307 · Cited by 738
CCAAT-Enhancer Binding Protein: A Component of a Differentiation Switch
Umek, R. M., Friedman, A. D., & McKnight, S. L. (1991) · Science · doi:10.1126/science.1987644 · Cited by 712
Self-citationHoltschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81348-3 · Cited by 644 · cited 6×
“C/EBPa( / ) fetal liver cells exposed in vivo to GM-CSF and IL-3 generate neutrophils, whereas knockdown of C/EBPb in these cells reduces their ability to do so (Hirai et al., 2006).”
BackgroundInfluentialThe DNA Binding Domain of the Rat Liver Nuclear Protein C/EBP Is Bipartite
Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1989) · Science · doi:10.1126/science.2494700 · Cited by 636
Multilineage Transcriptional Priming and Determination of Alternate Hematopoietic Cell Fates
Laslo, P., Spooner, C. J., Warmflash, A., Lancki, D. W., Lee, H.-J., Sciammas, R., Gantner, B. N., Dinner, A. R., & Singh, H. (2006) · Cell · doi:10.1016/j.cell.2006.06.052 · Cited by 632
Näär, A. M., Boutin, J.-M., Lipkin, S. M., Yu, V. C., Holloway, J. M., Glass, C. K., & Rosenfeld, M. G. (1991) · Cell · doi:10.1016/0092-8674(91)90021-p · Cited by 581
Advances in Bone Biology: The Osteoclast*
ROODMAN, G. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-4-308 · Cited by 549
Stein, B., Cogswell, P. C., & Baldwin, A. S. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.3964 · Cited by 520
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
Rosenbauer, F., Wagner, K., Kutok, J. L., Iwasaki, H., Le Beau, M. M., Okuno, Y., Akashi, K., Fiering, S., & Tenen, D. G. (2004) · Nature Genetics · doi:10.1038/ng1361 · Cited by 506 · cited 2×
“…of the PU.1 distal enhancer located at 14 kb results in 20% of normal PU.1 expression and loss of monopoiesis with preservation of granulopoiesis (Rosenbauer et al., 2004); and CRE-mediated deletion of PU.1 in adult mice preserves granulocytes at the expense of monocytes (Dakic et al., 2005).”
BackgroundZhang, P., Iwasaki-Arai, J., Iwasaki, H., Fenyus, M. L., Dayaram, T., Owens, B. M., Shigematsu, H., Levantini, E., Huettner, C. S., Lekstrom-Himes, J. A., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.11.006 · Cited by 504
Sauvageau, G., Lansdorp, P. M., Eaves, C. J., Hogge, D. E., Dragowska, W. H., Reid, D. S., Largman, C., Lawrence, H. J., & Humphries, R. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12223 · Cited by 497
Radomska, H. S., Huettner, C. S., Zhang, P., Cheng, T., Scadden, D. T., & Tenen, D. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4301 · Cited by 466 · cited 2×
“Within hematopoiesis, C/EBPa, C/EBPb and C/EBPd are predominantly expressed in the granulocyte, monocyte and eosinophil lineages (Scott et al., 1992; Muller et al., 1995; Radomska et al., 1998).”
BackgroundFriedman, A. D., Landschulz, W. H., & McKnight, S. L. (1989) · Genes & Development · doi:10.1101/gad.3.9.1314 · Cited by 464
Self-citationNegative cross-talk between hematopoietic regulators: GATA proteins repress PU.1
Zhang, P., Behre, G., Pan, J., Iwama, A., Wara-aswapati, N., Radomska, H. S., Auron, P. E., Tenen, D. G., & Sun, Z. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8705 · Cited by 459 · cited 4×
“…directly bind and repress transactivation by GATA-1 to downmodulate the erythroid program, just as GATA-1 inhibits PU.1 activity in cooperation with Rb to ensure continued maturation of erythroid and megakaryocytic cells (Rekhtman et al., 1999, 2003; Zhang et al., 1999, 2000; Stopka et al., 2005).”
BackgroundInfluentialRekhtman, N., Radparvar, F., Evans, T., & Skoultchi, A. I. (1999) · Genes & Development · doi:10.1101/gad.13.11.1398 · Cited by 454 · cited 3×
“…directly bind and repress transactivation by GATA-1 to downmodulate the erythroid program, just as GATA-1 inhibits PU.1 activity in cooperation with Rb to ensure continued maturation of erythroid and megakaryocytic cells (Rekhtman et al., 1999, 2003; Zhang et al., 1999, 2000; Stopka et al., 2005).”
BackgroundComprehensive Identification of Human bZIP Interactions with Coiled-Coil Arrays
Newman, J. R. S., & Keating, A. E. (2003) · Science · doi:10.1126/science.1084648 · Cited by 449 · cited 1×
“Challenging this conclusion are the results obtained with a zipper peptide chip in which none of the AP-1 or Maf LZs interact with C/EBP LZs, though Jun:Jun, Jun:Fos and MafB:Fos interactions are detected (Newman and Keating, 2003).”
ResultPip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447 · cited 2×
“1 within its central PEST domain on serine 148 allows interaction with interferon regulatory factor 4 (IRF-4) or IRF-8, the latter also designated ICSBP (Eisenbeis et al., 1995; Meraro et al., 1999).”
BackgroundPeptide ‘Velcro’: Design of a heterodimeric coiled coil
O'Shea, E. K., Lumb, K. J., & Kim, P. S. (1993) · Current Biology · doi:10.1016/0960-9822(93)90063-t · Cited by 437
Kataoka, K., Noda, M., & Nishizawa, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.700 · Cited by 435
Iwasaki, H., Somoza, C., Shigematsu, H., Duprez, E. A., Iwasaki-Arai, J., Mizuno, S.-I., Arinobu, Y., Geary, K., Zhang, P., Dayaram, T., et al. (2005) · Blood · doi:10.1182/blood-2005-03-0860 · Cited by 433 · cited 4×
“C/EBPa expression predominates in immature cells and is detected in the HSC, CMP and GMP, but not the common lymphoid (CLP) or megakeryocyte-erythroid progenitor (MEP) populations (Traver et al., 2001).”
BackgroundInfluentialTranslational control of C/EBPα and C/EBPβ isoform expression
Calkhoven, C. F., Müller, C., & Leutz, A. (2000) · Genes & Development · doi:10.1101/gad.14.15.1920 · Cited by 426
C/EBPβ is required for 'emergency' granulopoiesis
Hirai, H., Zhang, P., Dayaram, T., Hetherington, C. J., Mizuno, S.-I., Imanishi, J., Akashi, K., & Tenen, D. G. (2006) · Nature Immunology · doi:10.1038/ni1354 · Cited by 425 · cited 3×
“C/EBPa( / ) fetal liver cells exposed in vivo to GM-CSF and IL-3 generate neutrophils, whereas knockdown of C/EBPb in these cells reduces their ability to do so (Hirai et al., 2006).”
BackgroundZhang, D.-E., Hetherington, C. J., Chen, H.-M., & Tenen, D. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.373-381.1994 · Cited by 411
Scott, L., Civin, C., Rorth, P., & Friedman, A. (1992) · Blood · doi:10.1182/blood.v80.7.1725.1725 · Cited by 409
Self-citationDendritic cell potentials of early lymphoid and myeloid progenitors
Manz, M. G., Traver, D., Miyamoto, T., Weissman, I. L., & Akashi, K. (2001) · Blood · doi:10.1182/blood.v97.11.3333 · Cited by 398
Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes.
de The, H., Marchio, A., Tiollais, P., & Dejean, A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03394.x · Cited by 394
Barberis, A., Superti-Furga, G., & Busslinger, M. (1987) · Cell · doi:10.1016/0092-8674(87)90489-2 · Cited by 392
Christy, R. J., Kaestner, K. H., Geiman, D. E., & Lane, M. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2593 · Cited by 385
Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2
Person, R. E., Li, F.-Q., Duan, Z., Benson, K. F., Wechsler, J., Papadaki, H. A., Eliopoulos, G., Kaufman, C., Bertolone, S. J., Nakamoto, B., et al. (2003) · Nature Genetics · doi:10.1038/ng1170 · Cited by 385
Intrinsic Requirement for Zinc Finger Transcription Factor Gfi-1 in Neutrophil Differentiation
Hock, H., Hamblen, M. J., Rooke, H. M., Traver, D., Bronson, R. T., Cameron, S., & Orkin, S. H. (2003) · Immunity · doi:10.1016/s1074-7613(02)00501-0 · Cited by 384 · cited 3×
“Gfi-1( / ) mice or a patient expressing a mutant Gfi-1 display defects in neutrophil maturation subsequent to the promyelocyte stage; abnormal cells are present that retain primary granules and ring-shaped nuclei, but lack secondary and tertiary granule proteins and aberrantly express monocyte-restricted genes (Hock e…”
BackgroundYamanaka, R., Barlow, C., Lekstrom-Himes, J., Castilla, L. H., Liu, P. P., Eckhaus, M., Decker, T., Wynshaw-Boris, A., & Xanthopoulos, K. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13187 · Cited by 383 · cited 1×
“…all of the hematopoietic lineages, but have a defect in terminal neutrophil maturation resembling human cases of secondary granule deficiency (SGD; Yamanaka et al., 1997; Chumakov et al., 1997), and human cases of SGD harboring C/EBPe point mutations have been described (Lekstrom-Himes et al.,…”
BackgroundDahl, R., Walsh, J. C., Lancki, D., Laslo, P., Iyer, S. R., Singh, H., & Simon, M. C. (2003) · Nature Immunology · doi:10.1038/ni973 · Cited by 380
PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding
Zhang, P., Zhang, X., Iwama, A., Yu, C., Smith, K. A., Mueller, B. U., Narravula, S., Torbett, B. E., Orkin, S. H., & Tenen, D. G. (2000) · Blood · doi:10.1182/blood.v96.8.2641 · Cited by 368 · cited 1×
“…directly bind and repress transactivation by GATA-1 to downmodulate the erythroid program, just as GATA-1 inhibits PU.1 activity in cooperation with Rb to ensure continued maturation of erythroid and megakaryocytic cells (Rekhtman et al., 1999, 2003; Zhang et al., 1999, 2000; Stopka et al., 2005).”
BackgroundNguyen, H. Q., Hoffman-Liebermann, B., & Liebermann, D. A. (1993) · Cell · doi:10.1016/0092-8674(93)90660-i · Cited by 367
Laiosa, C. V., Stadtfeld, M., Xie, H., de Andres-Aguayo, L., & Graf, T. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.011 · Cited by 351 · cited 4×
“…at higher levels (DeKoter and Singh, 2000); exogenous PU.1 converts B or T cells to monocyte/macrophages but not granulocytes (Xie and Graf, 2004; Dionne et al., 2005; Laiosa et al., 2006); and PU.1 knockdown in embryonic stem cell-derived CD34þ cells favors B-cell formation (Zou et al., 2006).”
BackgroundResultInfluentialVinson, C. R., Hai, T., & Boyd, S. M. (1993) · Genes & Development · doi:10.1101/gad.7.6.1047 · Cited by 336 · cited 1×
“A scheme for predicting interaction strengths between LZs enumerates contacts between acidic residues D or E and basic residues R or K in the e and g salt bridge positions (Vinson et al., 1993).”
BackgroundSmith, L., Hohaus, S., Gonzalez, D., Dziennis, S., & Tenen, D. (1996) · Blood · doi:10.1182/blood.v88.4.1234.bloodjournal8841234 · Cited by 332
Genetic analysis of NF- B/Rel transcription factors defines functional specificities
Hoffmann, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg534 · Cited by 329
Transcriptional regulation of granulocyte and monocyte development
Friedman, A. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205324 · Cited by 324
Self-citationSynergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6.
Kunsch, C., Lang, R. K., Rosen, C. A., & Shannon, M. F. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.1.153 · Cited by 323
Lin, F. T., MacDougald, O. A., Diehl, A. M., & Lane, M. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9606 · Cited by 319
E2F Repression by C/EBPα Is Required for Adipogenesis and Granulopoiesis In Vivo
Porse, B. T., Pedersen, T. Å., Xu, X., Lindberg, B., Wewer, U. M., Friis-Hansen, L., & Nerlov, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00516-5 · Cited by 317
Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1
Karsunky, H., Zeng, H., Schmidt, T., Zevnik, B., Kluge, R., Schmid, K. W., Dührsen, U., & Möröy, T. (2002) · Nature Genetics · doi:10.1038/ng831 · Cited by 315 · cited 1×
“Gfi-1 is expressed in lymphoid and granulocytic cells but not in the monocyte lineage (Karsunky et al., 2002; Hock et al., 2003; Duan and Horwitz, 2003).”
BackgroundZweidler-Mckay, P. A., Grimes, H. L., Flubacher, M. M., & Tsichlis, P. N. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4024 · Cited by 305
MafB is an inducer of monocytic differentiation
Kelly, L. M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.9.1987 · Cited by 305
MafB Is an Interaction Partner and Repressor of Ets-1 That Inhibits Erythroid Differentiation
Sieweke, M. H., Tekotte, H., Frampton, J., & Graf, T. (1996) · Cell · doi:10.1016/s0092-8674(00)81081-8 · Cited by 302 · cited 1×
“MafB is expressed exclusively in monocyte/macrophage cells within hematopoiesis (Sieweke et al., 1996).”
BackgroundPU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis
Dakic, A., Metcalf, D., Di Rago, L., Mifsud, S., Wu, L., & Nutt, S. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050075 · Cited by 297
DeKoter, R. P., Walsh, J. C., & Singh, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4456 · Cited by 296 · cited 2×
“Expression of the MCSFR or granulocyte colony stimulating factor receptor (GCSFR) in PU.1( / ) marrow cells did not rescue myeloid development, indicating that PU.1 is required beyond induction of these cytokine receptors (DeKoter et al., 1998; Henkel et al., 1999).”
BackgroundNuchprayoon, I., Meyers, S., Scott, L. M., Suzow, J., Hiebert, S., & Friedman, A. D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5558 · Cited by 296
Self-citationMolecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors
Johnson, P. F. (2005) · Journal of Cell Science · doi:10.1242/jcs.02459 · Cited by 288
Grimes, H. L., Chan, T. O., Zweidler-McKay, P. A., Tong, B., & Tsichlis, P. N. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6263 · Cited by 279
Functions of c-Jun in Liver and Heart Development
Eferl, R., Sibilia, M., Hilberg, F., Fuchsbichler, A., Kufferath, I., Guertl, B., Zenz, R., Wagner, E. F., & Zatloukal, K. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.5.1049 · Cited by 275
c-Myc Is a Critical Target for C/EBPα in Granulopoiesis
Johansen, L. M., Iwama, A., Lodie, T. A., Sasaki, K., Felsher, D. W., Golub, T. R., & Tenen, D. G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.11.3789-3806.2001 · Cited by 263 · cited 4×
“The N terminus of C/EBPa is required for its E2F1-dependent cell cycle inhibition, potentially via Oncogene interaction with a co-repressor, although further elucidation of the mechanism underlying this phenomenon is required (Porse et al., 2001).”
BackgroundInfluentialCCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter.
Skalnik, D. G., Strauss, E. C., & Orkin, S. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55363-1 · Cited by 259
PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
Huang, G., Zhang, P., Hirai, H., Elf, S., Yan, X., Chen, Z., Koschmieder, S., Okuno, Y., Dayaram, T., Growney, J. D., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.7 · Cited by 259
Tribbles homolog 2 inactivates C/EBPα and causes acute myelogenous leukemia
Keeshan, K., He, Y., Wouters, B. J., Shestova, O., Xu, L., Sai, H., Rodriguez, C. G., Maillard, I., Tobias, J. W., Valk, P., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.012 · Cited by 238
Passegué, E., Jochum, W., Schorpp-Kistner, M., Möhle-Steinlein, U., & Wagner, E. F. (2001) · Cell · doi:10.1016/s0092-8674(01)00188-x · Cited by 236
Hp, K., AMATRUDA, T. T., IKEKAWA, N., Kobayashi, Y., & Hf, D. (1984) · PubMed · Cited by 230
C/EBP, c-Myb, and PU.1 Cooperate To Regulate the Neutrophil Elastase Promoter
Oelgeschläger, M., Nuchprayoon, I., Lüscher, B., & Friedman, A. D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4717 · Cited by 229 · cited 4×
“Beyond regulation lineage-specific genes, such as myeloperoxidase and neutrophil elastase (Nuchprayoon et al., 1994; Ford et al., 1996; Oelgeschläger et al., 1996), PU.”
BackgroundInfluentialSelf-citationMafB Is Essential for Renal Development and F4/80 Expression in Macrophages
Moriguchi, T., Hamada, M., Morito, N., Terunuma, T., Hasegawa, K., Zhang, C., Yokomizo, T., Esaki, R., Kuroda, E., Yoh, K., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00001-06 · Cited by 222
Endo, M., Mori, M., Akira, S., & Gotoh, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6245 · Cited by 220
Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B
Chen, H., Zhang, P., Voso, M., Hohaus, S., Gonzalez, D., Glass, C., Zhang, D., & Tenen, D. (1995) · Blood · doi:10.1182/blood.v85.10.2918.bloodjournal85102918 · Cited by 216
Tsai, S., & Collins, S. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7153 · Cited by 210
(1995) · PubMed · Cited by 206
Hsu, W., Kerppola, T. K., Chen, P. L., Curran, T., & Chen-Kiang, S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.268 · Cited by 200
Crosby, S. D., Puetz, J. J., Simburger, K. S., Fahrner, T. J., & Milbrandt, J. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.8.3835 · Cited by 197
Lekstrom-Himes, J. A., Dorman, S. E., Kopar, P., Holland, S. M., & Gallin, J. I. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1847 · Cited by 196
Balance of MafB and PU. 1 specifies alternative macrophage or dendritic cell fate
Bakri, Y., Sarrazin, S., Mayer, U. P., Tillmanns, S., Nerlov, C., Boned, A., & Sieweke, M. H. (2005) · Blood · doi:10.1182/blood-2004-04-1448 · Cited by 187
A direct physical association between ETS and AP-1 transcription factors in normal human T cells
Bassuk, A. G., & Leiden, J. M. (1995) · Immunity · doi:10.1016/1074-7613(95)90092-6 · Cited by 186 · cited 1×
“…promoters in the absence of an AP-1 cis element, and PU.1 and c-Jun cooperatively regulates the monocytic macrosialin and scavenger receptor promoters via distinct binding sites Oncogene (Moulton et al., 1994; Bassuk and Leiden, 1995; Li et al., 1998; Behre et al., 1999; Grondin et al., 2007).”
BackgroundBipotential B-macrophage progenitors are present in adult bone marrow
Montecino-Rodriguez, E., Leathers, H., & Dorshkind, K. (2001) · Nature Immunology · doi:10.1038/83210 · Cited by 185
Receptor for RACK1 Mediates Activation of JNK by Protein Kinase C
López-Bergami, P., Habelhah, H., Bhoumik, A., Zhang, W., Wang, L.-H., & Ronai, Z. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.025 · Cited by 184
Essential role of Jun family transcription factors in PU.1 knockdown–induced leukemic stem cells
Steidl, U., Rosenbauer, F., Verhaak, R. G. W., Gu, X., Ebralidze, A., Otu, H. H., Klippel, S., Steidl, C., Bruns, I., Costa, D. B., et al. (2006) · Nature Genetics · doi:10.1038/ng1898 · Cited by 184
c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor
Behre, G., Whitmarsh, A. J., Coghlan, M. P., Hoang, T., Carpenter, C. L., Zhang, D.-E., Davis, R. J., & Tenen, D. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4939 · Cited by 180 · cited 1×
“…promoters in the absence of an AP-1 cis element, and PU.1 and c-Jun cooperatively regulates the monocytic macrosialin and scavenger receptor promoters via distinct binding sites Oncogene (Moulton et al., 1994; Bassuk and Leiden, 1995; Li et al., 1998; Behre et al., 1999; Grondin et al., 2007).”
BackgroundPotential Autoregulation of Transcription Factor PU.1 by an Upstream Regulatory Element
Okuno, Y., Huang, G., Rosenbauer, F., Evans, E. K., Radomska, H. S., Iwasaki, H., Akashi, K., Moreau-Gachelin, F., Li, Y., Zhang, P., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2832-2845.2005 · Cited by 174 · cited 2×
“1 binds and activates its own promoter and distal enhancer, potentially to variable degrees in different lineages and developmental stages dependent on cooperating factors (Chen et al., 1995b; Okuno et al., 2005).”
BackgroundShimozaki, K., Nakajima, K., Hirano, T., & Nagata, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25184 · Cited by 169
Wang, X., Scott, E., Sawyers, C. L., & Friedman, A. D. (1999) · Blood · doi:10.1182/blood.v94.2.560 · Cited by 166 · cited 4×
“In contrast to C/EBPb, C/EBPa potently inhibits G1 to S cell cycle progression in a variety of lineages, including myeloid cells (Umek et al., 1991; Wang et al., 1999).”
BackgroundResultInfluentialSelf-citationSharf, R., Meraro, D., Azriel, A., Thornton, A. M., Ozato, K., Petricoin, E. F., Larner, A. C., Schaper, F., Hauser, H., & Levi, B.-Z. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9785 · Cited by 162 · cited 1×
“Tyrosine phosphorylation of IRF-8 prevents it from directly binding DNA, but allows it to do so after interaction with other IRFs or PU.1 (Sharf et al., 1997).”
BackgroundFriedman, A. D., & McKnight, S. L. (1990) · Genes & Development · doi:10.1101/gad.4.8.1416 · Cited by 162 · cited 1×
“…(2007) 26, 6816–6828 & 2007 Nature Publishing Group All rights reserved 0950-9232/07 $30.00 www.nature.com/onc spectrum of preferred DNA-binding sites (Friedman et al., 1989; Friedman and McKnight, 1990; Descombes and Schibler, 1991; Lin et al., 1993; Calkhoven et al., 2000; Cleaves et al., 2004).”
BackgroundInfluentialSelf-citationDunn, S., Coles, L., Lang, R., Gerondakis, S., Vadas, M., & Shannon, M. (1994) · Blood · doi:10.1182/blood.v83.9.2469.2469 · Cited by 155
Stopka, T., Amanatullah, D. F., Papetti, M., & Skoultchi, A. I. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600834 · Cited by 154 · cited 2×
“1 activity in cooperation with Rb to ensure continued maturation of erythroid and megakaryocytic cells (Rekhtman et al., 1999, 2003; Zhang et al., 1999, 2000; Stopka et al., 2005).”
BackgroundReddy, V. A., Iwama, A., Iotzova, G., Schulz, M., Elsasser, A., Vangala, R. K., Tenen, D. G., Hiddemann, W., & Behre, G. (2002) · Blood · doi:10.1182/blood.v100.2.483 · Cited by 152 · cited 4×
“The C/EBPa LZ also competes with c-Jun for interaction with PU.1 in the absence of DNA (Reddy et al., 2002), but when bound to DNA C/EBPa may in specific contexts, like C/EBPb, augment PU.1 activity as these factors cooperatively activate myeloid promoters (Oelgeschläger et al., 1996). c-Jun…”
BackgroundInfluentialMeraro, D., Hashmueli, S., Koren, B., Azriel, A., Oumard, A., Kirchhoff, S., Hauser, H., Nagulapalli, S., Atchison, M. L., & Levi, B.-Z. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6468 · Cited by 147 · cited 1×
“Interferon regulatory factor 8 and interaction with PU.1 Phosphorylation of PU.1 within its central PEST domain on serine 148 allows interaction with interferon regulatory factor 4 (IRF-4) or IRF-8, the latter also designated ICSBP (Eisenbeis et al., 1995; Meraro et al., 1999).”
BackgroundPhosphorylation of C/EBPα Inhibits Granulopoiesis
Ross, S. E., Radomska, H. S., Wu, B., Zhang, P., Winnay, J. N., Bajnok, L., Wright, W. S., Schaufele, F., Tenen, D. G., & MacDougald, O. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.675-686.2004 · Cited by 146
Friedman, A. D. (1996) · PubMed · Cited by 141
Self-citationMiller, M., Shuman, J. D., Sebastian, T., Dauter, Z., & Johnson, P. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300417200 · Cited by 138
Ford, A. M., Bennett, C. A., Healy, L. E., Towatari, M., Greaves, M. F., & Enver, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10838 · Cited by 134
Cloning of the Novel Human Myeloid-Cell-Specific C/EBP-ε Transcription Factor
Chumakov, A. M., Grillier, I., Chumakova, E., Chih, D., Slater, J., & Koeffler, H. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1375 · Cited by 134
Stop and Go: Anti-Proliferative and Mitogenic Functions of the Transcription Factor C/EBPβ
Sebastian, T., & Johnson, P. F. (2006) · Cell Cycle · doi:10.4161/cc.5.9.2733 · Cited by 134
Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages
Tamura, T., Thotakura, P., Tanaka, T. S., Ko, M. S. H., & Ozato, K. (2005) · Blood · doi:10.1182/blood-2005-01-0080 · Cited by 132
Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells
Jankovic, V., Ciarrocchi, A., Boccuni, P., DeBlasio, T., Benezra, R., & Nimer, S. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607894104 · Cited by 132
Gombart, A. F., Shiohara, M., Kwok, S. H., Agematsu, K., Komiyama, A., & Koeffler, H. P. (2001) · Blood · doi:10.1182/blood.v97.9.2561 · Cited by 132
Zhang, P., Iwama, A., Datta, M. W., Darlington, G. J., Link, D. C., & Tenen, D. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1173 · Cited by 130 · cited 1×
“Induction of C/EBPb in vitro may account for the ability of C/EBPa( / ) cells cultured in IL-3 or GMCSF, or transduced with the G-CSF receptor and cultured in G-CSF, to generate neutrophils (Zhang et al., 1998, 2002).”
The Role of C/EBPε in the Terminal Stages of Granulocyte Differentiation
Lekstrom‐Himes, J. A. (2001) · STEM CELLS · doi:10.1634/stemcells.19-2-125 · Cited by 127
Fetal liver myelopoiesis occurs through distinct, prospectively isolatable progenitor subsets
Traver, D., Miyamoto, T., Christensen, J., Iwasaki-Arai, J., Akashi, K., & Weissman, I. L. (2001) · Blood · doi:10.1182/blood.v98.3.627 · Cited by 127
Krishnaraju, K., Nguyen, H. Q., Liebermann, D. A., & Hoffman, B. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5499 · Cited by 124
Retinoic acid enhances growth of human early erythroid progenitor cells in vitro.
Douer, D., & Koeffler, H. P. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110507 · Cited by 122
C/EBPα binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment
Yeamans, C., Wang, D., Paz-Priel, I., Torbett, B. E., Tenen, D. G., & Friedman, A. D. (2007) · Blood · doi:10.1182/blood-2007-03-080291 · Cited by 118 · cited 1×
“Indeed, C/EBPa binds and activates the PU.1 promoter and distal enhancer, and the role of this activation in myelopoiesis will be discussed further below (Kummalue and Friedman, 2003; Yeamans et al., 2007).”
BackgroundSelf-citationThe JNK Are Important for Development and Survival of Macrophages
Himes, S. R., Sester, D. P., Ravasi, T., Cronau, S. L., Sasmono, T., & Hume, D. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2219 · Cited by 117 · cited 1×
“The JNK inhibitor SP600125 reduces the number of macrophages developing from murine marrow cells cultured in the presence of M-CSF (Himes et al., 2006).”
BackgroundPorse, B. T., Bryder, D., Theilgaard-Mönch, K., Hasemann, M. S., Anderson, K., Damgaard, I., Jacobsen, S. E. W., & Nerlov, C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050067 · Cited by 117 · cited 1×
“Interaction of E2F1 with the outer surface of the C/EBPa BR enables growth inhibition in myeloid cells and is required for their terminal differentiation (Porse et al., 2001, 2005; Wang et al., 2003).”
BackgroundHeath, V., Suh, H. C., Holman, M., Renn, K., Gooya, J. M., Parkin, S., Klarmann, K. D., Ortiz, M., Johnson, P., & Keller, J. (2004) · Blood · doi:10.1182/blood-2003-11-3963 · Cited by 114
NF-κB Is Required for UV-Induced JNK Activation via Induction of PKCδ
Liu, J., Yang, D., Minemoto, Y., Leitges, M., Rosner, M. R., & Lin, A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2005.12.020 · Cited by 113
Krishnaraju, K., Hoffman‐Liebermann, B., & Liebermann, D. A. (2001) · Blood · doi:10.1182/blood.v97.5.1298 · Cited by 108
Iwama, A., Osawa, M., Hirasawa, R., Uchiyama, N., Kaneko, S., Onodera, M., Shibuya, K., Shibuya, A., Vinson, C., Tenen, D. G., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011465 · Cited by 108
Heavey, B., Charalambous, C., Cobaleda, C., & Busslinger, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg380 · Cited by 107
Meraro, D., Gleit-Kielmanowicz, M., Hauser, H., & Levi, B.-Z. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6224 · Cited by 105 · cited 1×
“IRF-8 associates with IRF-1 or IRF-2 to bind an interferon-stimulated response element with two GAAANN half sites, and IRF-8:PU.1 complexes bind an Ets/IRF composite element containing a GGAA PU.1 site either preceded or followed by a single GAAANN element (Meraro et al., 2002; Tamura et al., 2005).”
BackgroundBourette, R. P., Myles, G. M., Choi, J., & Rohrschneider, L. R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.19.5880 · Cited by 105
Labrecque, J., Allan, D., Chambon, P., Iscove, N. N., Lohnes, D., & Hoang, T. (1998) · Blood · doi:10.1182/blood.v92.2.607 · Cited by 105
Targets of the transcriptional repressor oncoprotein Gfi-1
Duan, Z., & Horwitz, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031694100 · Cited by 104
Antonson, P., Stellan, B., Yamanaka, R., & Xanthopoulos, K. G. (1996) · Genomics · doi:10.1006/geno.1996.0319 · Cited by 103
Lawrence, H. J., Sauvageau, G., Ahmadi, N., Lopez, A. R., Beau, M. M. L., Link, M., Humphries, R. K., & Largman, C. (1995) · PubMed · Cited by 103
Luo, W., & Skalnik, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18203 · Cited by 102
Cross-talk between transcription factors NF-κB and C/EBP in the transcriptional regulation of genes
Xia, C., Cheshire, J. K., Patel, H. K., & Woo, P. M. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00083-6 · Cited by 102
PU.1 and pRB Interact and Cooperate To Repress GATA-1 and Block Erythroid Differentiation
Rekhtman, N., Choe, K. S., Matushansky, I., Murray, S., Stopka, T., & Skoultchi, A. I. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7460-7474.2003 · Cited by 102 · cited 1×
“…directly bind and repress transactivation by GATA-1 to downmodulate the erythroid program, just as GATA-1 inhibits PU.1 activity in cooperation with Rb to ensure continued maturation of erythroid and megakaryocytic cells (Rekhtman et al., 1999, 2003; Zhang et al., 1999, 2000; Stopka et al., 2005).”
BackgroundKrysinska, H., Hoogenkamp, M., Ingram, R., Wilson, N., Tagoh, H., Laslo, P., Singh, H., & Bonifer, C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01915-06 · Cited by 102 · cited 2×
“In this regard, PU.1 is sufficient to reorganize the chromatin structure of the MCSFR promoter in myeloid progenitors, but requires onset of Egr-2 expression to fully activate the intronic regulatory region designated the FIRE enhancer (Krysinska et al., 2007).”
BackgroundIdentification of a Fetal Hematopoietic Precursor with B Cell, T Cell, and Macrophage Potential
Lacaud, G., Carlsson, L., & Keller, G. M. (1998) · Immunity · doi:10.1016/s1074-7613(00)80648-2 · Cited by 101
T Cell Development in PU.1-Deficient Mice
Spain, L. M., Guerriero, A., Kunjibettu, S., & Scott, E. W. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2681 · Cited by 101 · cited 2×
“PU.1 is expressed in B-lymphoid, early T-lymphoid, granulocytic and monocytic cells (Klemsz et al., 1990; Chen et al., 1995a; Spain et al., 1999).”
BackgroundThe Transcriptional Repressor GFI-1 Antagonizes PU.1 Activity through Protein-Protein Interaction
Dahl, R., Iyer, S. R., Owens, K. S., Cuylear, D. D., & Simon, M. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607613200 · Cited by 96
Krishnaraju, K., Hoffman‐Liebermann, B., & Liebermann, D. A. (1998) · Blood · doi:10.1182/blood.v92.6.1957 · Cited by 96
Suh, H. C., Gooya, J., Renn, K., Friedman, A. D., Johnson, P. F., & Keller, J. R. (2006) · Blood · doi:10.1182/blood-2005-06-2216 · Cited by 95 · cited 2×
“, 2006); transplantation of mice with marrow transduced with C/EBPa increases the proportion of monocytes from 13 to 88%, while inhibiting erythropoiesis (Suh et al., 2006); and CLP or MEP isolated from mice expressing a C/EBPa-ER(T) transgene from the H2K promoter develop into macrophages upon exposure to 4-hydroxyta…”
BackgroundSelf-citationLee, S. L., Wang, Y., & Milbrandt, J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4566 · Cited by 93
NF-IL6 (C/EBPβ) Vigorously Activates il1b Gene Expression via a Spi-1 (PU.1) Protein-Protein Tether
Yang, Z., Wara-aswapati, N., Chen, C., Tsukada, J., & Auron, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000145200 · Cited by 92 · cited 2×
“The C/EBPb and PU.1 DNA-binding domains directly interact (Yang et al., 2000), and promoter-bound C/EBPb increases PU.1 interaction with a nearby cis element in the IL-1b promoter, augmenting gene induction (Grondin et al., 2007).”
Backgroundde Koning, J., Dong, F., Smith, L., Schelen, A., Barge, R., van der Plas, D., Hoefsloot, L., Lowenberg, B., & Touw, I. (1996) · Blood · doi:10.1182/blood.v87.4.1335.bloodjournal8741335 · Cited by 91
Müller, C., Kowenz‐Leutz, E., Grieser‐Ade, S., Graf, T., & Leutz, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00303.x · Cited by 91 · cited 1×
“Within hematopoiesis, C/EBPa, C/EBPb and C/EBPd are predominantly expressed in the granulocyte, monocyte and eosinophil lineages (Scott et al., 1992; Muller et al., 1995; Radomska et al., 1998).”
BackgroundWang, Q.-F., & Friedman, A. D. (2002) · Blood · doi:10.1182/blood.v99.8.2776 · Cited by 89
Self-citationc-Maf Induces Monocytic Differentiation and Apoptosis in Bipotent Myeloid Progenitors
Hegde, S. P., Zhao, J., Ashmun, R. A., & Shapiro, L. H. (1999) · Blood · doi:10.1182/blood.v94.5.1578 · Cited by 89
Moulton, K. S., Semple, K., Wu, H., & Glass, C. K. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4408 · Cited by 86
Eklund, E. A., Jalava, A., & Kakar, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m907915199 · Cited by 85
Induction of C/EBPα activity alters gene expression and differentiation of human CD34+ cells
Cammenga, J., Mulloy, J. C., Berguido, F. J., MacGrogan, D., Viale, A., & Nimer, S. D. (2003) · Blood · doi:10.1182/blood-2002-05-1546 · Cited by 85
Development of Macrophages with Altered Actin Organization in the Absence of MafB
Aziz, A., Vanhille, L., Mohideen, P., Kelly, L. M., Otto, C., Bakri, Y., Mossadegh, N., Sarrazin, S., & Sieweke, M. H. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00245-06 · Cited by 84
C/EBPα directs monocytic commitment of primary myeloid progenitors
Wang, D., D'Costa, J., Civin, C. I., & Friedman, A. D. (2006) · Blood · doi:10.1182/blood-2005-12-008763 · Cited by 84
Self-citationExpression of C/EBPβ from the C/ebpα gene locus is sufficient for normal hematopoiesis in vivo
Jones, L. C., Lin, M.-L., Chen, S.-S., Krug, U., Hofmann, W.-K., Lee, S., Lee, Y.-H., & Koeffler, H. P. (2002) · Blood · doi:10.1182/blood.v99.6.2032 · Cited by 84
Tsujimura, H., Nagamura-Inoue, T., Tamura, T., & Ozato, K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1261 · Cited by 83
Activation of SAPK/JNK Signaling by Protein Kinase Cδ in Response to DNA Damage
Yoshida, K., Miki, Y., & Kufe, D. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205485200 · Cited by 82
HOXA9 Activates Transcription of the Gene Encoding gp91 during Myeloid Differentiation
Bei, L., Lu, Y., & Eklund, E. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408138200 · Cited by 81
Taghon, T., Stolz, F., Smedt, M. D., Cnockaert, M., Verhasselt, B., Plum, J. R., & Leclercq, G. (2002) · Blood · doi:10.1182/blood.v99.4.1197 · Cited by 78
Induction of granulocytic differentiation by 2 pathways
Zhang, P., Nelson, E., Radomska, H. S., Iwasaki-Arai, J., Akashi, K., Friedman, A. D., & Tenen, D. G. (2002) · Blood · doi:10.1182/blood.v99.12.4406 · Cited by 78
Self-citationc-Maf Induces Monocytic Differentiation and Apoptosis in Bipotent Myeloid Progenitors
Hegde, S. P., Zhao, J., Ashmun, R. A., et al. (1999) · Blood · doi:10.1182/blood.v94.5.1578.417k18_1578_1589 · Cited by 77
Chih, D. Y., Chumakov, A. M., Park, D. J., Silla, A. G., & Koeffler, H. P. (1997) · Blood · doi:10.1182/blood.v90.8.2987 · Cited by 74
The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction.
Tagoh, H., Ingram, R., Wilson, N., Salvagiotto, G., Warren, A. J., Clarke, D., Busslinger, M., & Bonifer, C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600997 · Cited by 74 · cited 1×
“Pax5 also represses the MCSFR promoter through direct interaction (Tagoh et al., 2006).”
Backgroundc-Jun Homodimers Can Function as a Context-Specific Coactivator
Grondin, B., Lefrançois, M., Tremblay, M. R., Saint-Denis, M., Haman, A., Waga, K., Bédard, A., Tenen, D. G., & Hoang, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00936-06 · Cited by 67
Hsu, C.-L., King-Fleischman, A. G., Lai, A. Y., Matsumoto, Y., Weissman, I. L., & Kondo, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510304103 · Cited by 64
Liew, C. W., Rand, K. D., Simpson, R. J. Y., Yung, W. W., Mansfield, R. E., Crossley, M., Proetorius-Ibba, M., Nerlov, C., Poulsen, F. M., & Mackay, J. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602830200 · Cited by 63 · cited 1×
“The C-terminal zinc finger of GATA-1 competes with the DNA-binding BR of c-Jun for interaction with the Ets domain of PU.1 (Zhang et al., 1999; Liew et al., 2006).”
BackgroundWang, W., Wang, X., Ward, A. C., Touw, I. P., & Friedman, A. (2001) · Leukemia · doi:10.1038/sj.leu.2402094 · Cited by 63
Self-citationRangatia, J., Vangala, R. K., Singh, S. M., Peer Zada, A. A., Elsässer, A., Kohlmann, A., Haferlach, T., Tenen, D. G., Hiddemann, W., & Behre, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206664 · Cited by 62 · cited 1×
“Similarly, C/EBPa binds c-Jun, but not if the LZ is deleted from either of these proteins, and c-Jun inhibits C/EBPa DNA-binding (Rangatia et al., 2002, 2003).”
BackgroundRangatia, J., Vangala, R. K., Treiber, N., Zhang, P., Radomska, H., Tenen, D. G., Hiddemann, W., & Behre, G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8681-8694.2002 · Cited by 62 · cited 1×
“Similarly, C/EBPa binds c-Jun, but not if the LZ is deleted from either of these proteins, and c-Jun inhibits C/EBPa DNA-binding (Rangatia et al., 2002, 2003).”
BackgroundKautz, B., Kakar, R., David, E., & Eklund, E. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103381200 · Cited by 61 · cited 1×
“SHP2 activity diminishes during myeloid differentiation, allowing increased IRF-8 activity and facilitating differentiation in cooperation with PU.1 (Kautz et al., 2001; Kakar et al., 2005).”
BackgroundFukuchi, Y., Shibata, F., Ito, M., Goto‐Koshino, Y., Sotomaru, Y., Ito, M., Kitamura, T., & Nakajima, H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601199 · Cited by 60
Li, A. C., Guidez, F. R. B., Collier, J. G., & Glass, C. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5389 · Cited by 60 · cited 1×
“…promoters in the absence of an AP-1 cis element, and PU.1 and c-Jun cooperatively regulates the monocytic macrosialin and scavenger receptor promoters via distinct binding sites Oncogene (Moulton et al., 1994; Bassuk and Leiden, 1995; Li et al., 1998; Behre et al., 1999; Grondin et al., 2007).”
BackgroundLawson, N. D., Khanna‐Gupta, A., & Berliner, N. (1998) · Blood · doi:10.1182/blood.v91.7.2517 · Cited by 59
C/EBPɛ mediates myeloid differentiation and is regulated by the CCAAT displacement protein (CDP/cut)
Khanna-Gupta, A., Zibello, T., Sun, H., Lekstrom-Himes, J., & Berliner, N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141229598 · Cited by 59
Huang, W., Horvath, E., & Eklund, E. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607760200 · Cited by 58
Wang, Q., Cleaves, R., Kummalue, T., Nerlov, C., & Friedman, A. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206360 · Cited by 55
Self-citationPapin, S., Cazeneuve, C., Duquesnoy, P., Jéru, I., Sahali, D., & Amselem, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305166200 · Cited by 55
Paz‐Priel, I., Cai, D. H., Wang, D., Kowalski, J., Blackford, A. L., Liu, H., Heckman, C. A., Gombart, A. F., Koeffler, H. P., Boxer, L. M., et al. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0111 · Cited by 55
Self-citationSubversion of T lineage commitment by PU.1 in a clonal cell line system
Dionne, C. J., Tse, K. Y., Weiss, A. H., Franco, C. B., Wiest, D. L., Anderson, M. K., & Rothenberg, E. V. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.01.027 · Cited by 54 · cited 2×
“…at higher levels (DeKoter and Singh, 2000); exogenous PU.1 converts B or T cells to monocyte/macrophages but not granulocytes (Xie and Graf, 2004; Dionne et al., 2005; Laiosa et al., 2006); and PU.1 knockdown in embryonic stem cell-derived CD34þ cells favors B-cell formation (Zou et al., 2006).”
BackgroundLord, K. A., Abdollahi, A., Hoffman-Liebermann, B., & Liebermann, D. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.841-851.1993 · Cited by 54
(1994) · PubMed · Cited by 53
Commitment to the Monocytic Lineage Occurs in the Absence of the Transcription Factor PU.1
Henkel, G. W., McKercher, S. R., Leenen, P. J. M., & Maki, R. A. (1999) · Blood · doi:10.1182/blood.v93.9.2849 · Cited by 53
Interleukin 1β inhibits interleukin 6–mediated rat γ fibrinogen gene expression
Zhang, Z., & Fuller, G. M. (2000) · Blood · doi:10.1182/blood.v96.10.3466 · Cited by 52
Kummalue, T., & Friedman, A. D. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1202622 · Cited by 52
Self-citationTaschner, S., Koesters, C., Platzer, B., Jörgl, A., Ellmeier, W., Benesch, T., & Strobl, H. (2007) · Blood · doi:10.1182/blood-2006-04-020552 · Cited by 52
Williamson, E. A., Xu, H. N., Gombart, A. F., Verbeek, W., Chumakov, A. M., Friedman, A. D., & Koeffler, H. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.14796 · Cited by 50 · cited 1×
“C/EBPe has both trans-activation and trans-repression domains and is expressed as several alternatively spliced isoforms (Williamson et al., 1998; Lekstrom-Himes, 2001).”
BackgroundSelf-citationCleaves, R., Wang, Q., & Friedman, A. D. (2004) · Oncogene · doi:10.1038/sj.onc.1207172 · Cited by 49
Self-citationCadieux, C., Fournier, S., Peterson, A. C., Bédard, C., Bedell, B. J., & Nepveu, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4230 · Cited by 49
Bush, T. S., St. Coeur, M., Resendes, K. K., & Rosmarin, A. G. (2003) · Blood · doi:10.1182/blood.v101.1.311 · Cited by 47
Pierce, A., Heyworth, C. M., Nicholls, S. E., Spooncer, E., Dexter, T. M., Lord, J. M., Owen‐Lynch, P. J., Wark, G., & Whetton, A. D. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.6.1511 · Cited by 47
Lindsey, S. C., Huang, W., Wang, H., Horvath, E., Zhu, C., & Eklund, E. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608642200 · Cited by 45
Ortiz, M. A., Light, J., Maki, R. A., & Assa-Munt, N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2740 · Cited by 44
Maehara, K., Hasegawa, T., Xiao, H., Takeuchi, A., Abe, R., & Isobe, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00408-1 · Cited by 44
Bastie, J.-N., Balitrand, N., Guidez, F., Guillemot, I., Larghero, J., Calabresse, C., Chomienne, C., & Delva, L. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0412 · Cited by 43
Walkley, C. R., Purton, L. E., Snelling, H. J., Yuan, Y.-D., Nakajima, H., Chambon, P., Chandraratna, R. A. S., & McArthur, G. A. (2003) · Blood · doi:10.1182/blood-2003-07-2391 · Cited by 39
Zou, G.-M., Chen, J.-J., Yoder, M. C., Wu, W., & Rowley, J. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506218102 · Cited by 39
Gombart, A. F., Krug, U., O'Kelly, J., An, E., Vegesna, V., & Koeffler, H. P. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0504286 · Cited by 39
Leeanansaksiri, W., Wang, H., Gooya, J. M., Renn, K., Abshari, M., Tsai, S., & Keller, J. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7014 · Cited by 37
Kakar, R., Kautz, B., & Eklund, E. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0704429 · Cited by 32
(1994) · PubMed · Cited by 28
Anderson, K., Rusterholz, C., Månsson, R., Jensen, C. T., Bacos, K., Zandi, S., Sasaki, Y., Nerlov, C., Sigvardsson, M., & Jacobsen, S. E. W. (2007) · Blood · doi:10.1182/blood-2006-05-026021 · Cited by 27
Chumakov, A. M., Silla, A. G., Williamson, E. A., & Koeffler, H. P. (2007) · Blood · doi:10.1182/blood-2005-09-031963 · Cited by 26
Liu, H., Keefer, J. R., Wang, Q., & Friedman, A. D. (2003) · Blood · doi:10.1182/blood-2002-07-2212 · Cited by 24
Self-citationPaz‐Priel, I., Cai, D. H., Wang, D., Kowalski, J., Blackford, A. L., Liu, H., Heckman, C. A., Gombart, A. F., Koeffler, H. P., Boxer, L. M., et al. (2005) · Blood · doi:10.1182/blood.v106.11.2992.2992 · Cited by 8
Self-citationLewis, G., Marcus, R. E., Proctor, S. J., Gyldmark, M., Creeden, J., Aultman, R., & Jost, F. (2006) · Blood · doi:10.1182/blood.v108.11.345.345 · Cited by 6
Cai, D. H., Wang, D., Keefer, J. R., Hensley, K., & Friedman, A. D. (2006) · Blood · doi:10.1182/blood.v108.11.1170.1170 · Cited by 5
Self-citationArinobu, Y., Mizuno, S., Shigematsu, H., Ozawa, H., Chong, Y., Iwasaki, H., Kastner, P., Chan, S. H., & Akashi, K. (2006) · Blood · doi:10.1182/blood.v108.11.1656.1656 · Cited by 1
Cited by
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
“Of these, AP-1 and C/EBP family factors are required for macrophage development and function (Friedman, 2007), whereas E2A, EBF1, Pax5, and Oct-2 play important roles in the development and function of B cells (Medina and Singh, 2005).”
BackgroundTranscriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284
Neutrophils in cancer: Neutral no more
Coffelt, S. B., Wellenstein, M. D., & de Visser, K. E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.52 · Cited by 1,830
Microglial signatures and their role in health and disease
Butovsky, O., & Weiner, H. L. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0057-5 · Cited by 1,046
Transcriptional control of the inflammatory response
Medzhitov, R., & Horng, T. (2009) · Nature Reviews Immunology · doi:10.1038/nri2634 · Cited by 1,035
Metadata
- Authors
- Friedman, A. D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Friedman, A D
- ORCID
- Friedman, A D
- Venue
- Oncogene
- Published
- 2007-10-15
- Volume
- 26
- Issue
- 47
- Pages
- 6816-6828
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2055736709
- Cited by
- 427
- References
- 200
- Citations by year
- 2026: 13 · 2025: 11 · 2024: 13 · 2023: 11 · 2022: 17 · 2021: 32 · 2020: 23 · 2019: 14 · 2018: 20 · 2017: 31 · 2016: 23 · 2015: 28 · 2014: 22 · 2013: 32 · 2012: 28
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- granulopoiesis, monocyte development, myelopoiesis, PU.1, C/EBPα, C/EBPε, GATA-1, CFU-GM, lineage commitment, c-Jun, c-fos, Id1, EGR1, EGR2, vitamin D receptor, IRF8, retinoic acid receptor, HOXA10, GFI1, NF-κB, C/EBPβ, transcriptional regulation, hematopoiesis
- MeSH terms
- Animals, Cell Differentiation, Granulocytes, Humans, Monocytes, Transcription, Genetic, Leukopoiesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.